BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18573617)

  • 1. Promoting continuing care adherence among substance abusers with co-occurring psychiatric disorders following residential treatment.
    DeMarce JM; Lash SJ; Stephens RS; Grambow SC; Burden JL
    Addict Behav; 2008 Sep; 33(9):1104-12. PubMed ID: 18573617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of assertive continuing care on continuing care linkage, adherence and abstinence following residential treatment for adolescents with substance use disorders.
    Godley MD; Godley SH; Dennis ML; Funk RR; Passetti LL
    Addiction; 2007 Jan; 102(1):81-93. PubMed ID: 17207126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contracting, prompting, and reinforcing substance use disorder continuing care: a randomized clinical trial.
    Lash SJ; Stephens RS; Burden JL; Grambow SC; DeMarce JM; Jones ME; Lozano BE; Jeffreys AS; Fearer SA; Horner RD
    Psychol Addict Behav; 2007 Sep; 21(3):387-97. PubMed ID: 17874889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contracting, prompting and reinforcing substance use disorder continuing care.
    Lash SJ; Burden JL; Parker JD; Stephens RS; Budney AJ; Horner RD; Datta S; Jeffreys AS; Grambow SC
    J Subst Abuse Treat; 2013 Apr; 44(4):449-56. PubMed ID: 23122489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
    Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR
    Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of contracting and prompting substance abuse treatment entry: a pilot trial.
    Lash SJ; Gilmore JD; Burden JL; Weaver KR; Blosser SL; Finney ML
    Addict Behav; 2005 Mar; 30(3):415-22. PubMed ID: 15718059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Training substance abuse treatment staff to care for co-occurring disorders.
    Hunter SB; Watkins KE; Wenzel S; Gilmore J; Sheehe J; Griffin B
    J Subst Abuse Treat; 2005 Apr; 28(3):239-45. PubMed ID: 15857724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of a brief-intervention and continuity of care in enhancing attendance for treatment by adolescent substance users.
    Tait RJ; Hulse GK; Robertson SI
    Drug Alcohol Depend; 2004 Jun; 74(3):289-96. PubMed ID: 15194207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple diagnosis: dual diagnosis and HIV disease, Part 1.
    Douaihy AB; Jou RJ; Gorske T; Salloum IM
    AIDS Read; 2003 Jul; 13(7):331-2, 339-41. PubMed ID: 12889451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of engagement in continuing care following residential substance use disorder treatment.
    Harris AH; McKellar JD; Moos RH; Schaefer JA; Cronkite RC
    Drug Alcohol Depend; 2006 Sep; 84(1):93-101. PubMed ID: 16417977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of neighborhood environment on treatment continuity and rehospitalization in dually diagnosed patients discharged from acute inpatient care.
    Stahler GJ; Mennis J; Cotlar R; Baron DA
    Am J Psychiatry; 2009 Nov; 166(11):1258-68. PubMed ID: 19797433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences in treatment retention among individuals with co-occurring substance abuse and mental health disorders.
    Choi S; Adams SM; Morse SA; MacMaster S
    Subst Use Misuse; 2015 Apr; 50(5):653-63. PubMed ID: 25587672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated versus parallel treatment of co-occurring psychiatric and substance use disorders.
    Mangrum LF; Spence RT; Lopez M
    J Subst Abuse Treat; 2006 Jan; 30(1):79-84. PubMed ID: 16377455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attendance at Narcotics Anonymous and Alcoholics Anonymous meetings, frequency of attendance and substance use outcomes after residential treatment for drug dependence: a 5-year follow-up study.
    Gossop M; Stewart D; Marsden J
    Addiction; 2008 Jan; 103(1):119-25. PubMed ID: 18028521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Client retention in residential drug treatment for Latinos.
    Amodeo M; Chassler D; Oettinger C; Labiosa W; Lundgren LM
    Eval Program Plann; 2008 Feb; 31(1):102-12. PubMed ID: 18222144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Client and service characteristics associated with addiction treatment completion of clients with co-occurring disorders.
    Mangrum LF
    Addict Behav; 2009 Oct; 34(10):898-904. PubMed ID: 19303219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychosocial interventions for the long-term management of patients with severe mental illness and co-occurring substance use disorder.
    Brunette MF; Mueser KT
    J Clin Psychiatry; 2006; 67 Suppl 7():10-7. PubMed ID: 16961419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organizational capacity to address co-occurring substance use and psychiatric disorders: assessing variation by level of care.
    Lambert-Harris C; Saunders EC; McGovern MP; Xie H
    J Addict Med; 2013; 7(1):25-32. PubMed ID: 23188042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adolescents with co-occurring mental health and substance use disorders in primary care.
    Gee RL; Espiritu RC; Huang LN
    Adolesc Med Clin; 2006 Jun; 17(2):427-52. PubMed ID: 16814701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.